Risk of venous thrombosis with hormone replacement therapy [18]

Lancet

Volumn 348, Issue 9042, 1996, Pages 1668-

  McKenna, M J ^a   Scarabin, P Y ^a  

^a ST MICHAEL'S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; PROTHROMBIN;

BLOOD CLOTTING; DOSE RESPONSE; ESTROGEN BLOOD LEVEL; ESTROGEN RELEASE; FEMALE; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; LETTER; LONG TERM CARE; MENOPAUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK; RISK FACTOR; SYMPTOM; TRANSDERMAL DRUG ADMINISTRATION; VEIN THROMBOSIS; CHEMICALLY INDUCED DISORDER; ESTROGEN THERAPY; NOTE; THROMBOPHLEBITIS; INTRADERMAL DRUG ADMINISTRATION;

ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; RISK; THROMBOPHLEBITIS; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ESTROGENS;

EID: 0030443758     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65742-X     Document Type: Letter

References (5)

1. E Daly MP Vessey MM Hawkins Risk of venous thromboembolism in users of hormone replacement therapy Lancet 348 1996 977 980
2. H Jick LE Derby MW Myers C Vasilakis KM Newton Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens Lancet 348 1996 981 983
3. F Grodstein MJ Stampfer SZ Goldhaber Prospective study of exogenous hormones and risk of pulmonary embolism in women Lancet 348 1996 983 987
4. E Daly MP Vessey R Painter MM Hawkins Case-control study of venous thromboembolism risk in users of hormone replacement therapy Lancet 348 1996 1027
5. JP Vandenbroucke FM Helmerhorst Risk of venous thrombosis with hormone-replacement therapy Lancet 348 1996 972